Münchener Rückversicherungs-Gesellschaft AG buy Traumtanz
Start price
23.06.13
/
50%
€138.35
Target price
25.09.13
€150.00
Performance (%)
0.00%
End price
25.09.13
€138.35
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Münchener Rückversicherungs-Gesellschaft AG | -4.583% | -4.583% | 21.378% | 71.037% |
iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
According to Traumtanz what are the pros and cons of Münchener Rückversicherungs-Gesellschaft AG for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
EBIT growth >5% per year expected
Fair valuation
Cons
Comments by Traumtanz for this prediction
In the thread Münchener Rückversicherungs-Gesellschaft AG diskutieren
Munich Re.
Rueckversicherer werden einen immer wichtiger werdenden Platz einnehmen! Bei 130,- guter Einstiegspreis.
Stopped prediction by Traumtanz for Münchener Rückversicherungs-Gesellschaft AG
Münchener Rückversicherungs-Gesellschaft AG
Start price
Target price
Perf. (%)
€306.50
15.12.22
15.12.22
€312.00
15.12.23
15.12.23
3.85%
05.01.23
05.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
Münchener Rückversicherungs-Gesellschaft AG
Start price
Target price
Perf. (%)
€263.20
08.03.21
08.03.21
€280.00
08.03.22
08.03.22
-0.80%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
Münchener Rückversicherungs-Gesellschaft AG
Start price
Target price
Perf. (%)
€236.30
07.02.21
07.02.21
€250.00
2.12%
24.02.21
24.02.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected